Efficacy and undesirable effects of corticosteroid therapy experienced by palliative care specialists in Japan: A nationwide survey

Journal of Palliative Medicine

Volumn 14, Issue 7, 2011, Pages 840-845

  Matsuo, Naoki ^a   Morita, Tatsuya ^b   Iwase, Satoru ^c  

^a SAITAMA CANCER CENTER   (Japan)

^b Seirei Mikatabara General Hospital   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

AGED; ANOREXIA; ARTICLE; BACTERIAL PNEUMONIA; COMPRESSION FRACTURE; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DELIRIUM; DEPRESSION; DIABETES MELLITUS; DIGESTIVE SYSTEM PERFORATION; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; ELECTROLYTE DISTURBANCE; FATIGUE; GASTROINTESTINAL HEMORRHAGE; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; INSOMNIA; JAPAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MOON FACE; MYOPATHY; OSTEOPOROSIS; PALLIATIVE THERAPY; PEPTIC ULCER; PNEUMOCYSTIS PNEUMONIA; PREDICTION; PRESCRIPTION; SEPSIS; SUICIDE ATTEMPT; TERMINAL DISEASE; THRUSH; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; AGED; CROSS-SECTIONAL STUDIES; HEALTH CARE SURVEYS; HUMANS; JAPAN; OUTCOME ASSESSMENT (HEALTH CARE); PALLIATIVE CARE; SPECIALIZATION;

EID: 79959768766     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2011.0002     Document Type: Article

References (16)

1. Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG. Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer 1974;33:1607-1609.
2. Della Cuna GR, Pellegrini A, Piazzi M. Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients. A placebo-controlled, multicenter study. Eur J Cancer Clin Oncol 1989;25. 1817-1821. (Pubitemid 20084182)
3. Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. Action of oral methylprednisolone in terminal cancer patients. A prospective randomized double-blind study. Cancer Treat Rep 1985;69:751-754. (Pubitemid 15229409)
4. Hanks GW, Trueman T, Twycross RG. Corticosteroids in terminal cancer. A prospective analysis of current practice. Postgrad Med J 1983;59:702-706. (Pubitemid 14235540)
5. Needham PR, Daley AG, Lennard RF. Steroids in advanced cancer. Survey of current practice. BMJ 1992;305:999.
6. Twycross R. The risks and benefits of corticosteroids in advanced cancer. Drug Safety 1994;11:163-178. (Pubitemid 24283734)
7. Lundström SH, Fürst CJ. The use of corticosteroids in Swedish palliative care. Acta Oncol 2006;45:430-437. (Pubitemid 43884611)
8. Gannon C, McNamara P. A retrospective observation of corticosteroid use at the end of life in a hospice. J Pain Symptom Manage 2002;24:328-334. (Pubitemid 35379715)
9. Twycross R. Corticosteroids in advanced cancer. BMJ 1992; 305:969-970.
10. Radbruch L, Strasser F, Elsner F, Goncalves JF, Lge J, Kaasa S, Nauck F, Stone P; Research Steering Committee of the European Association for Palliative Care (EAPC). Fatigue in palliative care patients-an EAPC approach. Palliat Med 2008;22:13-32. (Pubitemid 351351367)
11. Wooldridge JE, Anderson CM, Perry MC. Corticosteroids in advanced cancer. Oncology (Williston Park) 2001; 15:225-234. (Pubitemid 33739483)
12. Mercadante S, Fulfaro F, Casuccio A. The use of corticosteroids in home palliative care. Support Care Cancer 2001; 9:386-389. (Pubitemid 32666891)
13. Hardy JR, Rees E, Ling J, Burman R, Feuer D, Broadley K, Stone P. A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med 2001;15:3-8. (Pubitemid 32103352)
14. Batchelor TT, Taylor LP, Thaler HT, Posner JB, DeAngelis LM. Steroid myopathy in cancer patients. Neurology 1997;48:1234-1238. (Pubitemid 27240540)
15. Stiefel FC, Breitbart WS, Holland JC. Corticosteroids in cancer. neuropsychiatric complications. Cancer Invest 1989; 7:479-491.
16. Jenkins CA, Bruera E. Difficulties in diagnosing neuropsychiatric complications of corticosteroids in advanced cancer patients. two case reports. J Pain Symptom Manage 2000;19. 309-317. (Pubitemid 30224697)